UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The company’s UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, individuals, and military service members; and health care coverage, and health and well-being services to individuals aged 50 and older addressing their needs for preventive and acute health care services. It also provides services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children’s Health Insurance Program, and health care programs; and health services, including commercial health and dental benefits. This segment serves through a network of 1 million physicians and other health care professionals, as well as approximately 6,000 hospitals and other facilities. Its OptumHealth segment offers health management services, including care delivery and management, wellness and consumer engagement, distribution, and health financial services. This segment serves individuals through programs offered by employers, payers, government entities, and directly with the care delivery systems. The company’s OptumInsight segment provides software and information products, advisory consulting services, and business process outsourcing and support services to hospitals, physicians, commercial health plans, government agencies, life sciences companies, and other organizations. Its OptumRx segment offers pharmacy care services and programs, including retail pharmacy network management, home delivery and specialty pharmacy, manufacturer rebate contracting and administration, benefit plan design and consultation, claims processing, and clinical program services, such as formulary management and compliance, drug utilization review, and disease and drug therapy management. The company was founded in 1974 and is based in Minnetonka, Minnesota.
UnitedHealth Group Incorporated earnings per share showed an increasing trend of 5.5% for the current fiscal year. The company’s expected EPS growth rate for next fiscal year is 894%.Analysts project EPS growth over the next 5 years at 14.78%. It has EPS annual growth over the past 5 fiscal years of 8% when sales grew 10.8. It reported 24.5% sales growth, and 14.2% EPS growth in the last quarter.
The stock is trading at $133.67, up 42.51% from 52-week low of $95. The stock trades down -1.07% from its peak of $135.11 and 11.65% above the consensus price target of $149.24. Its volume clocked up at 3.63 million shares which is higher than the average volume of 3.08 million shares. Its market capitalization currently stands at $127.41B.
0 yorum:
Yorum Gönder